Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study
Jason A. Roberts(Queensland Health), Jeffrey Lipman(Queensland Health), Despoina Koulenti(University of Thessaly), Claudio M. Martin(Western University), Veronique Stove(Ghent University Hospital), Matteo Bassetti(Ospedale Policlinico San Martino), Jordi Rello(Vall d'Hebron Hospital Universitari), Jacobus Ungerer(Queensland Health), Steven C. Wallis(The University of Queensland), Murat Akova(Hacettepe University), B. Sipinkoski(Queensland Health), Philippe Montravers(Université Claude Bernard Lyon 1), Andrew Rhodes(Zoetis (United States)), Therese Starr(The University of Queensland), Jan J. De Waele(Ghent University Hospital), Kirsi-Maija Kaukonen(Helsinki University Hospital), Brett McWhinney(Queensland Health)
Cited by 77
Related Papers
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k